Workday Founder's Rule 10b5-1 Sales Signal Smart Money Exit Amid 47% Stock Downtrend

The smart money is sending a clear signal, and it's not a bullish one. On March 23, David A. Duffield, a ten percent owner and co-founder of Workday, sold 107,500 shares of Class A Common Stock for approximately $14.7 million. The sale was executed under a pre-arranged Rule 10b5-1 plan, a common tool for insiders to manage personal finances. But the timing and context make this a significant red flag.

This transaction comes against a stark backdrop. Shares have declined 47% over the past six months, trading near $127. For an insider with a 10% stake, selling a major block of stock while the company is in a deep downtrend suggests a notable lack of skin in the game at these depressed prices. It's a classic sign that the founder may see limited upside ahead, or perhaps is simply prioritizing liquidity.

The pattern reinforces the concern. The Duffield Trust has been active, with multiple 10b5-1 sales in 2026. Earlier in the year, the trust sold 82,884 shares and 81,479 shares under similar pre-arranged plans. This isn't a one-off; it's a consistent, methodical reduction of position. While Rule 10b5-1 plans are legal and often used for diversification, their use by a major founder during a prolonged decline is a credibility check. It shows the insider is not betting against the sell-off by buying more, but rather taking money off the table.

The bottom line is one of alignment. When a founder sells a large chunk of stock while the stock is down sharply, it raises questions about their confidence in the near-term trajectory. The smart money is not waiting for a rebound; it's securing gains from a position that has already lost significant value.

Institutional Sentiment: A Split in the Smart Money

The insider move isn't happening in a vacuum. The broader institutional landscape shows a clear split, with some major players buying while the overall trend is one of selling. This divergence suggests the smart money is divided on Workday's path, but the net flow is a reduction of skin in the game.

The most dramatic exit came from Yarbrough Capital LLC. The fund slashed its position by 59.0% during the 4th quarter, selling 13,672 shares. This isn't a minor trim; it's a major de-risking move by a dedicated investor. That kind of reduction, especially in a single quarter, signals a loss of conviction. It aligns with the founder's selling, painting a picture of seasoned capital taking profits as the stock languishes.

Yet, this isn't a wholesale retreat. Some large holders are accumulating. Vanguard Group Inc. increased its position by 3.2% in the third quarter, buying an additional 684,872 shares. State Street Corp also added to its stake, lifting its position by 0.8% in the same period. These are not small bets; they are the moves of passive index funds and large institutional managers who often buy on dips. Their accumulation provides a floor of sorts, but it's being overwhelmed by the net selling.

The bottom line is in the numbers. Overall institutional ownership has decreased by 13.97% over the past quarter, with a net reduction of 31.87 million shares. That's a massive outflow from the institutional whale wallet. While Vanguard and State Street are buying, their purchases are dwarfed by the sales from funds like Yarbrough and others. The institutional sentiment score, which measures accumulation, reflects this reality. The net reduction of over 31 million shares is the dominant signal.

So, is the founder's sale an outlier? No, it's part of a larger trend of capital withdrawal. The smart money is split: some are buying the dip, but the majority are selling into the weakness. For an investor, that split is a red flag. It means there's no clear consensus on a bottom, and the institutional weight is shifting away. When the whales are selling en masse, even the buyers can't stop the tide.

Financial Health vs. Valuation: The Core Business Reality

The stock price tells one story, but the financials tell another. Workday's underlying business remains robust, with fiscal 2026 total revenues of $9.55 billion, up 13.1% year-over-year. The engine is subscription growth, which climbed 14.5% to $8.83 billion. This isn't just top-line expansion; it's high-quality, recurring revenue that provides visibility. The company also generated operating cash flows of $2.939 billion, a strong 19.4% increase. That kind of cash generation is the lifeblood of a healthy enterprise, funding operations, debt, and even a significant share buyback program.

Yet, the valuation has detached from this operational reality. The stock trades at a premium P/E ratio of 48.13. That multiple prices in near-perfect execution and relentless growth. The problem is, the market's patience for that perfection may be wearing thin. The founder's sale and the institutional exodus suggest smart money is questioning whether those lofty expectations are still warranted. When a company's growth is already baked into the price, any stumble in momentum can trigger a sharp re-rating.

The disconnect is stark. The business is growing, but the stock is down 47% over six months. That kind of decline typically signals that future growth expectations have been ratcheted down. The smart money is betting that the premium valuation is now too high relative to the perceived risk. They're not selling because the company is failing; they're selling because they believe the risk/reward has shifted. The skin in the game is moving out, even as the cash flows keep rolling in.

Catalysts and Risks: What to Watch Next

The bearish signal from insider selling is clear, but the stock's fate hinges on near-term catalysts. The next earnings report will be the first major test, offering a direct look at whether growth is slowing or margins are under pressure. Management guidance for the coming quarter will be critical. Any hint of a slowdown in subscription revenue growth or a margin compression from rising costs could confirm the smart money's loss of confidence. The market has already priced in perfection; any stumble in execution could trigger another sharp re-rating.

Equally important is monitoring the 10b5-1 plan for additional sales. David Duffield's March sale was under a pre-arranged plan adopted in December, but it was not his first. The Duffield Trust has executed multiple 10b5-1 sales in 2026. If the plan triggers more sales in the coming weeks or months, it would signal a continued, methodical reduction of skin in the game by a major insider. This would reinforce the narrative that the founder sees limited upside at current levels and is prioritizing liquidity over holding through a potential downturn.

The biggest risk, however, is a loss of confidence from the major institutional holders who are currently buying. Vanguard and State Street are accumulating, but they are not alone. The net institutional flow is a massive outflow of over 31 million shares. If these large holders decide their accumulation is a mistake and begin selling, it could trigger a broader institutional sell-off. Their scale means their moves can move the needle. The split in the smart money is already a red flag; a coordinated retreat from the buyers would be the final confirmation that the institutional whale wallet is closing its doors.